p38 MAPK mediates the expression of type I collagen induced by TGF-β2 in human retinal pigment epithelial cells ARPE-19

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 7, 2004, Pages 2431-2437

  Kimoto, Kenichi ^a   Nakatsuka, Kazuo ^a   Matsuo, Noritaka ^a   Yoshioka, Hidekatsu ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; COLLAGEN TYPE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; COLLAGEN SYNTHESIS; ENZYME ACTIVATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; ENZYME INHIBITORS; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEPTIDE FRAGMENTS; PIGMENT EPITHELIUM OF EYE; PLASMIDS; PROCOLLAGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 3142579185     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-1276     Document Type: Article

References (52)

1. Rachal WF, Burton TC. Changing concepts of failures after retinal detachment surgery. Arch Ophthalmol. 1979;97:480-483.
2. The Retina Society Terminology Committee. The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology. 1983;90:121-125.
3. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res. 1999;18:167-190.
4. Campochiaro PA. Pathogenic mechanism in proliferative vitreoretinopathy. Arch Ophthalmol. 1997;115:237-241.
5. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol. 1995;79:953-960.
6. Machemer R, Van Horn D, Aaeberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol. 1978;85:181-191.
7. Jergan JA, Pepose JS, Michels RG, et al. Proliferative vitreoretinopathy membranes: an immunohistochemical study. Ophthalmology. 1989;96:801-810.
8. Scheiffarth F, Kampik A, Gunther H, von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol. 1988;226:357-361.
9. Slack JL, Liska DJ, Bornstein P. Regulation of expression of the type I collagen gene. Am J Med Genet. 1993;45:140-151.
10. Connor TB Jr, Roberts AB, Spom MB, et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. J Clin Invest. 1989;83:1661-1666.
11. Gonzalez-Avila G, Lozano D, Manjarrez ME, et al. Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy. Ophthalmology. 1995;102:1400-1405.
12. Pfeffer BA, Flanders KC, Guerin CJ, Danielpour D, Anderson DH. Transforming growth factor beta 2 is the predominant isoform in the neural retina, retinal pigment epithelium-choroid and vitreous of the monkey eye. Exp Eye Res. 1994;59:323-333.
13. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med. 1994;331:1286-1292
14. Zhou S, Zawel L, Lengauer C, Kinzler KW, Vogelstein B Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol Cell. 1998;2:121-127.
15. Hanafusa HE, Ninomiya-Tsuji J, Masuyama N, et al. Involvement of the p38 mitogen activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem. 1999;274:27161-27167.
16. Sato M, Shegogue D, Gore EA, Smith EA, Mcdermott PJ, Trojanowska M. Role of p38 MAPK in transforming growth factor beta stimulation of collagen production by scleroderma and healthy dermal fibroblasts. J Invest Dermatol. 2002;118:704-711.
17. Dunn KC, Aotaki-Keen AE, Putkey FR, Hjelmeland LM. ARPE-19, a human retinal pigment epithelium cell line with differentiated properties. Exp Eye Res. 1996;62:155-169.
18. Aarskog NK, Vedeler CA. Real-time quantitative polymerase chain reaction. A new method that detects both the peripheral myelin protein 22 duplication in Charcot-Marie-Tooth type 1A disease and the peripheral myelin protein 22 deletion in hereditary neuropathy with liability to pressure palsies. Hum Genet. 2000;107:494-498.
19. Hata R, Senoo H. L-Ascorbic acid 2-phosphate stimulates collagen accumulation, cell proliferation, and formation of a three-dimensional tissue like substance by skin fibroblasts. J Cell Physiol. 1989;138:8-16.
20. Inagaki Y, Truter S, Ramirez F. Transforming growth factor-β P stimulates α2(I) collagen gene expression through a cis-acting element that contains an Sp1-binding site. J Biol Chem. 1994;269:14828-14834.
21. Poncelet AC, Caestecker M, Schnaper W. The TGF-β/SMAD signaling pathway is present and functional in human mesangial cells. Kidney Int. 1999;56:1354-1365.
22. Inagaki Y, Nemoto T, Nakao A, et al. Interaction between GC box binding factors and smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem. 2001;276:16573-16579.
23. Hayashida T, Caestecker M, Schnaper HW. Cross-talk between ERK MAPkinase and Smad-signaling pathway enhances TGF-β dependent responses in human mesangial cells. FASEB J. 2003.
24. Jamenez SA, Varga J, Olsen A, et al. Functional analysis of human α1(I) procollagen gene promoter. J Biol Chem. 1994;269:12684-12691.
25. Atfi A, Djelloul S, Chastre E, Davis R, Gespach C. Evidence for a role of rho-like GTPases and stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK) in transforming growth factor β-mediated signaling. J Biol Chem. 1997;272:1429-1432.
26. Chin BY, Petrache I, Choi AMK, Choi ME. Transforming growth factor-β1 rescues serum deprivation-induced apoptosis via the mitogen-activated protein kinase (MAPK) pathway in macrophages. J Biol Chem. 1999;274:11362-11368.
27. Hartsough MT, Frey RS, Zipfel PA, et al. Altered transforming growth factor β signaling in epithelial cells when ras activation is blocked. J Biol Chem. 1996;271:22368-22375.
28. Macias-Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFβ receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 1996;87:1215-1224.
29. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. TβRI phosphorylation of smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem. 1997;272:27678-27685.
30. Chen SJ, Yuan W, Mori Y, Levenson A, Trojanowska M, Varga J. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-β. Involvement of Smad3. J Invest Dermatol. 1999;112:49-57.
31. Zhang W, Ou J, Inagaki Y, Greenwel P, Ramirez F. Synergistic cooperation between Sp1 and Smad3/Smad4 mediates transforming growth factor-β1 stimtfiation of α2(I) collagen gene transcription. J Biol Chem. 2000;275:39237-39245.
32. Poncelet AC, Schnaper HW. Sp1 and Smad proteins cooperate to mediate transforming growth factor-beta 1-induced alpha 2(I) collagen expression in human glomerular mesangial cells. J Biol Chem. 2001;276:6983-6992.
33. Inagaki Y, Mamura M, Kanamaru Y, et al. Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol. 2001;187:117-123.
34. Heldin CH, Miyazono K, Dijke P. TGF-β signaling from cell membrane to nucleus through Smad proteins. Nature. 1997;390:465-471.
35. Huang HC, Murtaugh LC, Vizw PD, Whitman M. Identification of a potential regulator of early transcriptional responses to mesoderm inducers in the frog embryo. EMBO J. 1995;14:5965-5973.
36. Derynck R, Zang Y, Feng XH. Smad: Transcriptional activators of TGF-β responses. Cell. 1998;95:737-740.
37. Zawel L, Dai JL, Buckhaults P, et al. Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell. 1998;1:611-617.
38. Watanabe H, de Caestecker MP, Yamada Y. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-β-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem. 2001;276:14466-14473.
39. Blanchette F, Rivard N, Rudd P, Grondin F, Attisano L, Dubois CM. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor-β1-induced furin gene transactivation. J Biol Chem. 2001;276:33986-33994.
40. Kretzschmar M, Doody J, Timokhima I, Massague J. A mechanism of repression of TGF-β/Smad signaling by oncogenic Ras. Genes Dev. 1999;13:804-816.
41. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. Activations of ERK1/2 and JNK by transforming growth factor-β negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Bio Chem. 2002;277:36024-36031.
42. Ravanti L, Toriseva M, Penttinen R, et al. Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor-β via p38 mitogen-activated protein kinase. FASEB J. 2001;15:1098-1100.
43. Daian T, Ohtsuru A, Rogounovith T, et al. Insulin-like growth factor-I enhances transforming growth factor-β-induced extracellular matrix protein production through the p38/activating transcriptional factor-2 signaling pathway in keloid fibroblasts. J Invest Dermatol. 2003;120:956-962.
44. Cao Q, Mak KM, Lieber CS. DLPC decreases TGF-β1-induced collagen mRNA by inhibiting p38 MAPK in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2002;283:G1051-G1061.
45. Chin BY, Mohsenin A, Li SX, Choi AM, Choi ME. Stimulation of pro-alpha(I) collagen by TGF-β (I) in mesangial cells: role of the p38 MAPK pathway. Am J Physiol. 2001;280:F495-F504.
46. Hayashida t, Poncelet AC, Hubchak SC, Schnaper HW. TGF-β1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 1999;56:1710-1720.
47. Reunanen N, Foschi M, Han J, Kähäri VM. Activation of extracellular signal-regulated kinase1/2 inhibits type I collagen expression by human skin fibroblasts. J Biol Chem. 2000;275:34634-34639.
48. Geller SF, Lewis GP, Fisher SK. FGFR1, signaling, and AP-1 expression after retinal detachment: reactive Müller and RPE cells. Invest Ophthalmol Vis Sci. 2001;42:1363-1369.
49. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. Activation and role of MAP kinase-dependent pathway in retinal pigment epithelium cells: ERK and RPE cell proliferation. Invest Ophthalmol Vis Sci. 2002;43:3091-3098.
50. Liou GI, Matragoon S, Samuel S, et al. MAP kinase and β-catenin signaling in HGF induced RPE migration. Mol Vis. 2002;8:483-493.
51. Hecquet C, Lefevre G, Valtink M, Engelmann K, Mascarelli F. Activation and role of MAP kinase-dependent pathway in retinal pigment epithelium cella: JNK1, p38 kinase, and cell death. Invest Ophthalmol Vis Sci. 2003;44:1320-1329.
52. Bian ZM, Elner SG, Yoshida A, Elner VM. Human RPE-monocyte co-culture induces chemokine gene expression through activation of MAPK and NIK cascade. Exp Eye Res. 2003;76:573-583.